OLD Category: CAR-T

June 12, 2023 / Mol Ther

  • Haas AR, Golden RJ, Litzky LA, Engels B, Zhao L, Xu F, Taraszka JA, Ramones M, Granda B, Chang WJ, Jadlowsky J, Shea KM, Runkle A, Chew A, Dowd E, Gonzalez V, Chen F, Liu X, Fang C, Jiang S, Davis MM, Sheppard NC, Zhao Y, Fraietta JA, Lacey SF, Plesa G, Melenhorst JJ, Mansfield K, Brogdon JL, Young RM, Albelda SM, June CH, Tanyi JL.
Multiple clinical studies have treated mesothelin (MSLN)-positive solid tumors by administering MSLN-directed chimeric antigen receptor (CAR) T cells. Although these products are generally safe, efficacy is limited. Therefore, we generated…
April 7, 2022 / Cancers (Basel)

  • de Groot FA, de Groen RAL, van den Berg A...Diepstra A, Nijland M, Vermaat JSP
March 28, 2022 / Cells

  • Beider K, Itzhaki O, Schachter J...Avigdor A, Nagler A, Besser MJ
March 21, 2022 / Nat Med

  • Narayan V, Barber-Rotenberg JS, Jung IY...June CH, Fraietta JA, Haas NB
February 10, 2022 / Oncoimmunology

  • Sonzogni O, Zak DE, Sasso MS, Lear R, Muntzer A, Zonca M, West K, Champion BR, Rottman JB
February 2, 2022 / Clin Transl Immunology

  • Nishimoto KP, Barca T, Azameera A...An Z, Panuganti S, Hayes SM
January 27, 2022 / Blood

  • Funk CR, Wang S, Chen KZ...Spencer HT, Shanmugam M, Waller EK
October 14, 2021 / Commun Biol

  • Jarvis LB, Rainbow DB, Coppard V...Peruzzotti-Jametti L, Wicker LS, Jones JL
October 12, 2021 / Nat Med

  • Cordoba S, Onuoha S, Thomas S...Wynn R, Pule M, Amrolia PJ
September 1, 2021 / Cytotherapy

  • Kavanagh H, Dunne S, Martin DS, McFadden E, Gallagher L, Schwaber J, Leonard S, O'Dea S
August 24, 2021 / J Blood Med

  • Castaneda-Puglianini O, Chavez JC
May 13, 2021 / J Transl Genet Genom

  • Cox MJ, Kenderian SS